183 related articles for article (PubMed ID: 34843812)
1. Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis.
Chong WH; Saha BK; Tan CK
J Hosp Infect; 2022 Feb; 120():98-109. PubMed ID: 34843812
[TBL] [Abstract][Full Text] [Related]
2. Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: A Swiss multicenter cohort study on IAPA in critically ill influenza patients.
Waldeck F; Boroli F; Zingg S; Walti LN; Wendel-Garcia PD; Conen A; Pagani JL; Boggian K; Schnorf M; Siegemund M; Abed-Maillard S; Michot M; Que YA; Bättig V; Suh N; Kleger GR; Albrich WC
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13059. PubMed ID: 36394086
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis.
Lu LY; Lee HM; Burke A; Li Bassi G; Torres A; Fraser JF; Fanning JP
Chest; 2024 Mar; 165(3):540-558. PubMed ID: 37742914
[TBL] [Abstract][Full Text] [Related]
4. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.
Vanderbeke L; Janssen NAF; Bergmans DCJJ; Bourgeois M; Buil JB; Debaveye Y; Depuydt P; Feys S; Hermans G; Hoiting O; van der Hoven B; Jacobs C; Lagrou K; Lemiale V; Lormans P; Maertens J; Meersseman P; Mégarbane B; Nseir S; van Oers JAH; Reynders M; Rijnders BJA; Schouten JA; Spriet I; Thevissen K; Thille AW; Van Daele R; van de Veerdonk FL; Verweij PE; Wilmer A; Brüggemann RJM; Wauters J;
Intensive Care Med; 2021 Jun; 47(6):674-686. PubMed ID: 34050768
[TBL] [Abstract][Full Text] [Related]
5. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
Chong WH; Saha BK; Neu KP
Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
[TBL] [Abstract][Full Text] [Related]
6. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
7. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.
Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I
APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291
[TBL] [Abstract][Full Text] [Related]
8. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
[TBL] [Abstract][Full Text] [Related]
9. Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study.
Krifors A; Blennow O; Påhlman LI; Gille-Johnson P; Janols H; Lipcsey M; Källman J; Tham J; Stjärne Aspelund A; Ljungquist O; Hammarskjöld F; Hällgren A; De Geer L; Lemberg M; Petersson J; Castegren M
Infect Dis (Lond); 2024 Feb; 56(2):110-115. PubMed ID: 37897800
[TBL] [Abstract][Full Text] [Related]
10. Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study.
Waldeck F; Boroli F; Suh N; Wendel Garcia PD; Flury D; Notter J; Iten A; Kaiser L; Schrenzel J; Boggian K; Maggiorini M; Pugin J; Kleger GR; Albrich WC
Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):1915-1923. PubMed ID: 32494955
[TBL] [Abstract][Full Text] [Related]
11. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
13. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
Nyga R; Maizel J; Nseir S; Chouaki T; Milic I; Roger PA; Van Grunderbeeck N; Lemyze M; Totet A; Castelain S; Slama M; Dupont H; Sendid B; Zogheib E
Am J Respir Crit Care Med; 2020 Sep; 202(5):708-716. PubMed ID: 32407157
[No Abstract] [Full Text] [Related]
14. The Extent of Aspergillosis in Critically Ill Patients With Severe Influenza Pneumonia: A Multicenter Cohort Study.
Coste A; Frérou A; Raute A; Couturaud F; Morin J; Egreteau PY; Blanc FX; Reignier J; Tadié JM; Tran A; Pronier C; Coste-Burel M; Nevez G; Gangneux JP; Le Pape P; Ansart S; Tonnelier JM; Bretonnière C; Aubron C
Crit Care Med; 2021 Jun; 49(6):934-942. PubMed ID: 33591000
[TBL] [Abstract][Full Text] [Related]
15. Invasive pulmonary aspergillosis associated with viral pneumonitis.
Dewi IM; Janssen NA; Rosati D; Bruno M; Netea MG; Brüggemann RJ; Verweij PE; van de Veerdonk FL
Curr Opin Microbiol; 2021 Aug; 62():21-27. PubMed ID: 34034082
[TBL] [Abstract][Full Text] [Related]
16. Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis.
Wurster S; Pantaleón García J; Albert ND; Jiang Y; Bhoda K; Kulkarni VV; Wang Y; Walsh TJ; Evans S; Kontoyiannis DP
J Infect Dis; 2023 Apr; 227(7):901-906. PubMed ID: 36611269
[TBL] [Abstract][Full Text] [Related]
17. Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
Reizine F; Pinceaux K; Lederlin M; Autier B; Guegan H; Gacouin A; Luque-Paz D; Boglione-Kerrien C; Bacle A; Le Daré B; Launey Y; Lesouhaitier M; Painvin B; Camus C; Mansour A; Robert-Gangneux F; Belaz S; Le Tulzo Y; Tadié JM; Maamar A; Gangneux JP
J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34063556
[TBL] [Abstract][Full Text] [Related]
18. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
19. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.
Delsuc C; Cottereau A; Frealle E; Bienvenu AL; Dessein R; Jarraud S; Dumitrescu O; Le Maréchal M; Wallet F; Friggeri A; Argaud L; Rimmelé T; Nseir S; Ader F
Crit Care; 2015 Dec; 19():421. PubMed ID: 26631029
[TBL] [Abstract][Full Text] [Related]
20. Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model.
Seldeslachts L; Vanderbeke L; Fremau A; Reséndiz-Sharpe A; Jacobs C; Laeveren B; Ostyn T; Naesens L; Brock M; Van De Veerdonk FL; Humblet-Baron S; Verbeken E; Lagrou K; Wauters J; Vande Velde G
Virulence; 2021 Dec; 12(1):2493-2508. PubMed ID: 34546839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
